COVID-19
The COVID-19 pandemic accelerated the development of mRNA technologies, most notably with the creation of mRNA vaccines targeting SARS-CoV-2. While these vaccines helped control the pandemic, their potential may extend beyond infectious diseases, with growing interest in their potential application ...
touchONCOLOGY spoke to Professor Pamela Kearns (University of Birmingham, UK) to discuss her experience as President of SIOP Europe during the COVID-19 pandemic, and the biggest achievements of the European paediatric oncology community during that time. Questions How would you ...
In December 2019, an outbreak of pneumonia of unknown aetiology was observed in the Chinese city of Wuhan, capital of Hubei province. By January 2020, this outbreak was attributed to a novel virus classified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the ...
touchONCOLOGY are joined by the EAU Section of Oncological Urology (ESOU) Chairman Professor Morgan Rouprêt to discuss what we have learned from the COVID-19 pandemic, how this has impacted the care of cancer patients and what we can do ...
We were delighted to catch up with Prof Mark Lawler to discuss the challenges that the COVID-19 pandemic has had on cancer care in Europe, and the key objectives and messages of the Time To Act: COVID-19 & Cancer campaign. ...
touchONCOLOGY joins Dr Scott Shepherd (London, UK), to discuss his presentation at ESMO 2021 on the CAPTURE study exploring adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients. To view Part One click here. Questions 1. How did immune responses relate ...
touchONCOLOGY joins Dr Scott Shepherd (London, UK), to discuss his presentation at ESMO 2021 on the CAPTURE study exploring adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients. To view Part Two click here. Questions 1. What were the aims and ...
touchONCOLOGY joins Dr Markus Joerger (St. Gallen Cancer Center, Switzerland) at ESMO 2021 to discuss the outcome and prognostic factors of COVID-19 infection in cancer patients. Questions 1. What were the objectives of the SAKK 80/20 study? (00:15-00:50) 2. Could you give us a ...
Advanced age and other comorbid conditions put patients with chronic lymphocytic leukaemia (CLL) at an increased risk of morbidity and mortality from SARS-CoV-2 infection, with early studies showing case fatality rates of over 30% in patients with CLL with symptomatic COVID-19.1,2 ...
The COVID-19 pandemic has had a huge impact on us all, but particularly patients with cancer. Prof. Mark Lawler tells touchONCOLOGY about the data he presented at this year’s European Cancer Summit, the challenges patients with cancer face as ...
The COVID-19 pandemic has had a direct impact on cancer care. Prof. Florence Joly discusses the challenges and lessons learned when treating patients with cancer during the pandemic and lockdown period. The late-breaking abstract ‘Impact of the COVID-19 pandemic on ...
Assoc. Prof. Trisha Wise-Draper joins touchONCOLOGY to discuss the impact of the COVID-19 in cancer care and lessons learned through the findings of the COVID-19 and Cancer Consortium Registry (CCC19). The late-breaking abstract ‘Systemic cancer treatment-related outcomes in patients with ...
touchONCOLOGY joins Dr Deborah Doroshow to discuss the recent COVID-19 and Cancer Outcomes Study (CCOS), and how the COVID-19 pandemic has caused disparities in cancer care. Dr Doroshow presented her late-breaking abstract, 'Disparities in cancer during the COVID-19 pandemic: COVID-19 ...
Watch a panel of cancer nursing experts from Europe discuss how the COVID-19 pandemic has impacted cancer care working practices, the need to maintain a healthy workforce, as well as practical measures to support cancer care nurses during the pandemic.
“It is difficult to evaluate what did not happen.” – Academician, LV Gromashevsky The COVID-19 pandemic may be considered the first global health catastrophe in the past 100 years, since it has affected not only economic, political and medical paradigms, but also ...
On June 25, 2020, a panel of MASCC experts led a virtual discussion on how the COVID-19 pandemic impacts cancer patients and how healthcare professionals can support them during the pandemic. Topics included the next steps after the crisis is resolved; precautions ...
As of June 2020, the COVID-19 pandemic has swept across 188 countries infecting more than 10 million people worldwide.1 Despite its proximity to China, Pakistan’s death toll from the virus, as of the end of June 2020, has fortunately remained under 5,000;1 however, the ...
Watch a panel of cancer nursing experts discuss the impact of the COVID-19 pandemic on cancer care delivery in Europe, including how the pandemic has impacted cancer patients and their families and practical strategies to support cancer treatment and care for patients during the pandemic.
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
